Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

The article was primarily about Pardes which doesn't look that promising to me -albeit possibly better than Pfizer. In a recent pitch they mentioned that they were going to have to run more phase 1 in the USA, and the once a day dosing without boosting seemed a bit more tentative.

While it is well down the road and a lot of has to happen first, I wonder about how easy it will be to scale up ENTA's or Pardes' drugs. Pfizer says the chemistry of their drug is extremely complex takes several months to get the finished product, which limits how quickly and how much they can produce. I wonder whether such issues will arise for ENTA or Pardes.